Want to learn about the most sophisticated diagnostic technology ever conceived by humans? From me???
#MolPath #PathSky #MedEd
#MolPath #PathSky #MedEd
Registration is open for our Molecular Genetic Pathology Review Course in May. It's for those:
➤ preparing for a certification exam
➤ looking to earn CE credits
➤ in need of a refresher in molecular pathology core concepts.
Faculty and schedule: www.amp.org/events/molec...
➤ preparing for a certification exam
➤ looking to earn CE credits
➤ in need of a refresher in molecular pathology core concepts.
Faculty and schedule: www.amp.org/events/molec...
March 17, 2025 at 3:55 PM
🚨Spoiler alert: Primary cutaneous NUT adnexal carcinoma can metastasize—but long-term outcomes remain unclear. We're about to report an almost 20-year follow-up on this new entity. Stay tuned! 😆🔬🧬
#dermpath #pathology #molpath #IHCPath #MDACCPath
#dermpath #pathology #molpath #IHCPath #MDACCPath
May 31, 2025 at 11:53 PM
🚨Spoiler alert: Primary cutaneous NUT adnexal carcinoma can metastasize—but long-term outcomes remain unclear. We're about to report an almost 20-year follow-up on this new entity. Stay tuned! 😆🔬🧬
#dermpath #pathology #molpath #IHCPath #MDACCPath
#dermpath #pathology #molpath #IHCPath #MDACCPath
Welcome to Boston! We're kicking off #AMPath2025: a week showcasing and celebrating the innovation, collaboration and discoveries that advance #molpath worldwide!
November 11, 2025 at 2:01 PM
Welcome to Boston! We're kicking off #AMPath2025: a week showcasing and celebrating the innovation, collaboration and discoveries that advance #molpath worldwide!
🔬 The first GUPS / IAP (Arab Division) Joint Educational Series is NEXT WEEK!
📅 February 4, 2026
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP #PathologyEducation
📅 February 4, 2026
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP #PathologyEducation
January 26, 2026 at 5:58 PM
🔬 The first GUPS / IAP (Arab Division) Joint Educational Series is NEXT WEEK!
📅 February 4, 2026
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP #PathologyEducation
📅 February 4, 2026
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP #PathologyEducation
Consider @jmdiagn.bsky.social for publication of your next #molpath #moldx advancements. JMD is the official journal of
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics
Submission is free!
www.editorialmanager.com/jmdi/default...
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics
Submission is free!
www.editorialmanager.com/jmdi/default...
March 10, 2025 at 8:48 PM
Consider @jmdiagn.bsky.social for publication of your next #molpath #moldx advancements. JMD is the official journal of
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics
Submission is free!
www.editorialmanager.com/jmdi/default...
@ampath.bsky.social. #SolidTumor #InfectiousDisease #Informatics #Hematopathology #Genetics
Submission is free!
www.editorialmanager.com/jmdi/default...
Consider @JMDiagn for your next manuscript in #moldx and #molpath. We consider papers looking to improve diagnosis of #genetic conditions, #infectiousdisease, #hemathopathology disorders, #solidtumor, and healthcare #informatics.
Submission is free: https://loom.ly/LylFFhM
Submission is free: https://loom.ly/LylFFhM
August 8, 2025 at 1:56 PM
Consider @JMDiagn for your next manuscript in #moldx and #molpath. We consider papers looking to improve diagnosis of #genetic conditions, #infectiousdisease, #hemathopathology disorders, #solidtumor, and healthcare #informatics.
Submission is free: https://loom.ly/LylFFhM
Submission is free: https://loom.ly/LylFFhM
🔔 This Wednesday! Don’t miss the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
February 3, 2026 at 1:07 AM
🔔 This Wednesday! Don’t miss the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
🔍 Discover the ins and outs of multi-gene assays in #breastcancer treatment! This one-hour webinar covers common tests and their practical applications. Learn more and register ➡️ educate.amp.org/local/catalo...
#Genomics #molpath
#Genomics #molpath
January 13, 2025 at 1:42 PM
🔍 Discover the ins and outs of multi-gene assays in #breastcancer treatment! This one-hour webinar covers common tests and their practical applications. Learn more and register ➡️ educate.amp.org/local/catalo...
#Genomics #molpath
#Genomics #molpath
🔔 Happening TODAY!
Join us for the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register now: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
Join us for the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register now: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
February 4, 2026 at 11:39 AM
🔔 Happening TODAY!
Join us for the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register now: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
Join us for the first GUPS / IAP (Arab Division) Joint Educational Series
📅 February 4, 2026 | ⏰ 12:00–2:00 PM EST
👉 Register now: us02web.zoom.us/webinar/regi...
#GUpath #MolPath #GUPS #IAP
Hear from #AMPath2025 plenary speaker Heidi Rehm, Ph.D., about the #molpath field's efforts to address challenges with identifying and reporting variants of uncertain significance (VUS) during germline genetic testing.
🔎 View details: https://amp25.amp.org/program/amp-2025-program/
🔎 View details: https://amp25.amp.org/program/amp-2025-program/
October 15, 2025 at 1:01 PM
Hear from #AMPath2025 plenary speaker Heidi Rehm, Ph.D., about the #molpath field's efforts to address challenges with identifying and reporting variants of uncertain significance (VUS) during germline genetic testing.
🔎 View details: https://amp25.amp.org/program/amp-2025-program/
🔎 View details: https://amp25.amp.org/program/amp-2025-program/
Include a Graphical Abstract with your next #moldx or #molpath submission to @JMDiagn!
Need help generating an eye catching and concise image for your work? Use the @Elsevier resources here to help: https://www.elsevier.com/researcher/author/tools-and-resources/graphical-abstract
Need help generating an eye catching and concise image for your work? Use the @Elsevier resources here to help: https://www.elsevier.com/researcher/author/tools-and-resources/graphical-abstract
July 23, 2025 at 1:15 PM
Include a Graphical Abstract with your next #moldx or #molpath submission to @JMDiagn!
Need help generating an eye catching and concise image for your work? Use the @Elsevier resources here to help: https://www.elsevier.com/researcher/author/tools-and-resources/graphical-abstract
Need help generating an eye catching and concise image for your work? Use the @Elsevier resources here to help: https://www.elsevier.com/researcher/author/tools-and-resources/graphical-abstract
📅 FREE webinar at 1 p.m. ET on 12/19: Explore the multifaceted dimensions of #DEI within #molpath and the importance of supporting underrepresented #molecular lab professionals. Sign up here: us06web.zoom.us/webinar/regi... 🔬
December 12, 2024 at 11:01 PM
📅 FREE webinar at 1 p.m. ET on 12/19: Explore the multifaceted dimensions of #DEI within #molpath and the importance of supporting underrepresented #molecular lab professionals. Sign up here: us06web.zoom.us/webinar/regi... 🔬
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social media platform of your choice. Entries are already being accepted!
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social media platform of your choice. Entries are already being accepted!
Details and contest entry form: www.amp.org/educatio....
December 19, 2024 at 1:00 PM
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social media platform of your choice. Entries are already being accepted!
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social media platform of your choice. Entries are already being accepted!
Details and contest entry form: www.amp.org/educatio....
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
December 19, 2024 at 5:17 PM
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
December 26, 2024 at 1:00 PM
Start thinking about your entry for our 2025 Social Media Challenge!
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Post a short tutorial on any #molpath topic on the social platform of your choice.
Use the hashtag #AMPtutorials. You could win free registration to #AMPath2025.
Details and contest entry form: www.amp.org/educatio....
Taking T-Acute Lymphoblastic Leukemia (T-ALL) a ‘NOTCH’ higher (1/n): #AMPtutorials #AMPath24 #molpath
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
August 17, 2025 at 2:28 PM
Taking T-Acute Lymphoblastic Leukemia (T-ALL) a ‘NOTCH’ higher (1/n): #AMPtutorials #AMPath24 #molpath
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
#pathtwitter #pathX #path2path #PathX
T-ALL is a hematological malignancy characterized by the infiltration of bone marrow with hematopoietic cells expressing immature T-cell markers.
We should start a discussion about reducing workload without reducing quality. Molpath in Barrett's without dysplasia us a good starting point...
#PathSky Our healthcare/insurance system is so broken it’s provoking vigilante murder. But now we’re sending molecular testing on Barrett’s?? Good use of resources, everyone. 🙄
December 17, 2024 at 8:04 AM
We should start a discussion about reducing workload without reducing quality. Molpath in Barrett's without dysplasia us a good starting point...
Attention #molpath students, postdocs and residents: Join AMP now for FREE as an associate member and enjoy exclusive member benefits for the duration of your training (up to 7 years): https://www.amp.org/membership/member-benefits/
January 14, 2026 at 4:00 PM
Attention #molpath students, postdocs and residents: Join AMP now for FREE as an associate member and enjoy exclusive member benefits for the duration of your training (up to 7 years): https://www.amp.org/membership/member-benefits/
Attention #molpath students, postdocs and residents: Join AMP now for FREE as an associate member and enjoy exclusive member benefits for the duration of your training (up to 7 years): https://www.amp.org/membership/member-benefits/
January 5, 2026 at 4:00 PM
Attention #molpath students, postdocs and residents: Join AMP now for FREE as an associate member and enjoy exclusive member benefits for the duration of your training (up to 7 years): https://www.amp.org/membership/member-benefits/
🥳 Congratulations to our 3rd #AMPtutorials social media challenge winner Ting Zhao for her post on TMPRSS2::ERG fusion in prostate cancer! x.com/TingZhaoPath...
She’s won free registration to #AMPath25. The challenge reopens in November for chances to win registration for AMP 2026!
She’s won free registration to #AMPath25. The challenge reopens in November for chances to win registration for AMP 2026!
Ting Zhao, MD on X: "In this #AMPtutorials, we will discuss the role of the TMPRSS2::ERG fusion in prostate cancer (PCa), and its therapeutic implications. What do you know about the fusion? 🧬 #Molpath #GUpath #ProstateCancer @AMPath @MGBpathology @MGHPathology https://t.co/PjWGJimikd" / X
In this #AMPtutorials, we will discuss the role of the TMPRSS2::ERG fusion in prostate cancer (PCa), and its therapeutic implications. What do you know about the fusion? 🧬 #Molpath #GUpath #ProstateCancer @AMPath @MGBpathology @MGHPathology https://t.co/PjWGJimikd
x.com
August 25, 2025 at 9:05 PM
🥳 Congratulations to our 3rd #AMPtutorials social media challenge winner Ting Zhao for her post on TMPRSS2::ERG fusion in prostate cancer! x.com/TingZhaoPath...
She’s won free registration to #AMPath25. The challenge reopens in November for chances to win registration for AMP 2026!
She’s won free registration to #AMPath25. The challenge reopens in November for chances to win registration for AMP 2026!
🌟 Calling all AMP regular members! We're seeking nominations for elected leadership roles. Nominate yourself or a colleague by Jan. 17. View the available roles and submit your nominations here: www.surveymonkey.com... #molpath #Leadership
December 17, 2024 at 1:01 PM
🌟 Calling all AMP regular members! We're seeking nominations for elected leadership roles. Nominate yourself or a colleague by Jan. 17. View the available roles and submit your nominations here: www.surveymonkey.com... #molpath #Leadership